CD44 and brain neoplasm: Next, we evaluate whether the high expressions of collagen type I receptors (ITGAV, ITGB8, SDC1, SDC4, and CD44) in tumor tissues, i.e., tumor receptors, are related with the prognosis of patients with brain tumor.